Document Type : Original Article

Authors

1 Oral and Dental Diseases Research Center, Kerman University of Medical Sciences, Kerman, Iran.

2 Dept. Oral and Dental Diseases Research Center, Kerman University of Medical Sciences, Kerman, Iran.

3 Dept. of Radiation Oncology, Neuroscience Research Center, Kerman University of Medical Sciences, Kerman, Iran.

4 Social Determinants on Oral Health Research Center, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran.

10.30476/dentjods.2023.95143.1839

Abstract

Statement of the Problem: Reduced saliva production or changes in the quality of saliva are major causes of xerostomia as a perceptual disease.
Purpose: This study aimed to measure validity and reliability of the Persian version of the xerostomia inventory (XI) questionnaire.
Materials and Method: This cross-sectional study was performed in Kerman in 2021. The sample size for this study was 100 people. To test the discriminant validity of XI, 50 healthy people (control group) and 50 people undergoing or recovering from laryngeal radiation (xerostomia group) were chosen. Cronbach's alpha coefficient was used to determine internal consistency, and the intra-cluster correlation (ICC) coefficient was used to determine test-retest reliability after two weeks. To evaluate the concurrent validity, the relationship between the total score of the questionnaire and the golden question, which was defined as “How often do you have dry mouth?” was measured.
Results: Cronbach's alpha and ICC coefficient for the total XI score were 0.84 and 0.95, respectively. The mean ages of patients in the radiotherapy group and the healthy participants were 59±7.5 and 41.1±6.6 years, respectively. Participants who were having or had had laryngeal radiotherapy had a significantly higher mean total XI score than healthy individuals (p< 0.001).
Conclusion: The Persian version of the Xerostomia Inventory is a valid and reliable tool for assessing xerostomia.

Highlights

Shahla Kakoei (Google Scholar)

Keywords

  • Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R. Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev. 2011; 12: CD008934.
  • Rayman S, Dincer E, Almas K. Xerostomia. Diagnosis and management in dental practice. N Y State Dent J. 2010; 76: 24-27.
  • Kakoei S, Nekouei AH, Kakooei S, Najafipour H. The effect of demographic characteristics on the relationship between smoking and dry mouth in Iran: a cross-sectional, case-control study. Epidemiol Health. 2021; 43: e2021017.
  • Gerdin EW, Einarson S, Jonsson M, Aronsson K, Johansson I. Impact of dry mouth conditions on oral health-related quality of life in older people. Gerodontology. 2005; 22: 219-226.
  • Millsop JW, Wang EA, Fazel N. Etiology, evaluation, and management of xerostomia. Clin Dermatol. 2017; 35: 468-476.
  • Nekouei AH, Kakooei S, Najafipour H, Kakoei S. Oral Health Determinants among Opium Users in Kerman, Iran. Addict Health. 2021; 13: 156-164.
  • Ouanounou A. Xerostomia in the Geriatric Patient: Causes, Oral Manifestations, and Treatment. Compend Contin Educ Dent. 2016; 37: 306-311.
  • Ursache M, Grădinaru I, Nechifor M, Cherciu-Ciubotaru B. Implication ale xerostomiei în dishomeostazia orală [Implications of xerostomia in oral dishomeostasis]. Rev Med Chir Soc Med Nat Iasi. 2006; 110: 432-437.
  • Yamamoto K, Kurihara M, Matsusue Y, Komatsu Y, Tsuyuki M, Fujimoto T, et al. Atrophic change of tongue papilla in 44 patients with Sjögren syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107: 801-805.
  • Nekouei AH, Kakooei S, Najafipour H, Kakoei S. Oral Health determinants among opium users in Kerman, Iran. Addict Health. 2021; 13: 156-164.
  • Villa A, Connell CL, Abati S. Diagnosis and management of xerostomia and hyposalivation. Ther Clin Risk Manag. 2015; 11: 45-51.
  • Navazesh M, Kumar SK. University of Southern California School of measuring salivary flow: challenges and opportunities. J Am Dent Assoc. 2008; 139 Suppl: 35S-40S.
  • Dirix P, Nuyts S, Van den Bogaert W. Radiation-induced xerostomia in patients with head and neck cancer: a literature review. Cancer. 2006; 107: 2525-2534.
  • Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001; 50: 695-704. 
  • Santiago PHR, Song Y, Hanna K, Nair R. Degrees of xerostomia? A Rasch analysis of the Xerostomia Inventory. Community Dent Oral Epidemiol. 2020; 48: 63-71.
  • Van*der*Putten GJ, Brand HS, Schols JM, de*Baat C. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents. Clin Oral Investig. 2011; 15: 185-192.
  • Başakcı*Çalık B, Gür Kabul E, Keskin A, Bozcuk S, Şenol H, Çobankara V. Translation and validation of a Turkish version of the Xerostomia Inventory XI in patients with primary Sjögren’s syndrome. Turk J Med Sci. 2021; 51: 2477-2484.
  • Hohenberger R, Baumann I, Plinkert PK, Brinster R, Krisam J, Affolter A, et al. Validating the Xerostomia Inventory in a radiation-induced xerostomia population in German language. Oral Dis. 2019; 25: 1744-1750.
  • Amaral JPAR, Marques DNDS, Thomson WM, Vinagre ARR, da*Mata ADSP. Validity and reliability of a Portuguese version of the Summated Xerostomia Inventory-5. Gerodontology. 2018; 35: 33-37.
  • Da*Mata AD, da*Silva*Marques DN, Freitas FM, de*Almeida*Rato*Amaral JP, Trindade RT, Barcelos FA, et al Patto JM. Translation, validation, and construct reliability of a Portuguese version of the Xerostomia Inventory. Oral Dis. 2012; 18: 293-298.
  • Lee J, Koh JH, Kwok SK, Park SH. Translation and validation of a Korean Version of the Xerostomia Inventory in Patients with Primary Sjögren's Syndrome. J Korean Med Sci. 2016; 31: 724-728.
  • Serrano C, Fariña MP, Pérez C, Fernández M, Forman K, Carrasco M. Translation and validation of a Spanish version of the xerostomia inventory. Gerodontology. 2016; 33: 506-512. 
  • GkavelaG, Kossioni A, Lyrakos G, Karkazis H, Volikas K. Translation and preliminary validation of the Greek version of the Xerostomia Inventory in older people. European Geriatric Medicine. 2015; 6: 237-240.
  • Jiang N, Wei S, Mårtensson J, Zhao Y, Årestedt K. Assessment of Radiation-Induced Xerostomia: Validation of the Xerostomia Questionnaire in Chinese Patients With Head and Neck Cancer. Cancer Nurs. 2021; 44: E68-E75.
  • Lin SC, Jen YM, Chang YC, Lin CC. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire. J Pain Symptom Manage. 2008; 36: 141-148.
  • Wimardhani YS, Rahmayanti F, Maharani DA, Mayanti W, Thomson WM. The validity and reliability of the Indonesian version of the Summated Xerostomia Inventory. Gerodontology. 2021; 38: 82-86.
  • Thomson WM, van*der*Putten GJ, de*Baat C, Ikebe K, Matsuda K, Enoki K, Hopcraft MS, Ling GY. Shortening the xerostomia inventory. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 112: 322-327.
  • Minicucci EM, Pires RB, Vieira RA, Miot HA, Sposto MR. Assessing the impact of menopause on salivary flow and xerostomia. Aust Dent J. 2013; 58: 230-234.
  • Vosoughi AR, Roustaei N, Mahdaviazad H. American Orthopaedic Foot and Ankle Society ankle-hindfoot scale: A cross-cultural adaptation and validation study from Iran. Foot Ankle Surg. 2018; 24: 219-223.
  • Mahdaviazad H, Roustaei N, Masoumpour MB, Razeghinejad MR. Psychometric properties of the Glaucoma Quality of Life-15 questionnaire: Use of explanatory factor analysis. J Curr Ophthalmol. 2018; 30: 211-216.
  • Tavakol M, Dennick R. Making sense of Cronbach's alpha. Int J Med Educ. 2011; 2: 53-55.
  • Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016; 15: 155-163.